Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Omnichannel strategies to revolutionize the healthcare professional experience

Partners come on board GSK’s plan for Stevenage life science hub

UK adds £175m funding to clinical research recovery drive

StartUp Health takes a multidisciplinary approach to fight type 1 diabetes

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome

iptacopan

novartis innit

News/ News/ R&D

Novartis’ iptacopan hits the mark in rare kidney disease C3G

Phil Taylor C3 glomerulopathy, complement therapeutics, iptacopan, nephrology, Novartis, rare disease 0 Comment

Novartis has chalked up another successful trial for its targeted factor B inhibitor iptacopan, an orally-active drug trying

X

Novartis’ iptacopan hits the mark in rare kidney disease C3G

https://pharmaphorum.com/news/novartis-iptacopan-hits-the-mark-in-rare-kidney-disease-c3g/

novartis innit

News/ News/ R&D

EHA21: Novartis trumpets iptacopan as oral alternative to antibodies in PNH

Phil Taylor Alexion, complement therapeutics, EHA 2021, Haematology, iptacopan, Novartis, rare disease, Soliris, Ultomiris 0 Comment

The mainstay of therapy for the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH) is Alexion’s infusion therapy Soliris,

X

EHA21: Novartis trumpets iptacopan as oral alternative to antibodies in PNH

https://pharmaphorum.com/news/eha21-novartis-trumpets-iptacopan-as-oral-alternative-to-antibodies-in-pnh/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Partners come on board GSK's plan for Stevenage life science hub
Teva poaches Vertex exec as new head of R&D
After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome
UK adds £175m funding to clinical research recovery drive

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com